Palvella Therapeutics (NASDAQ:PVLA – Get Free Report)‘s stock had its “buy” rating reissued by Chardan Capital in a report issued on Monday,Benzinga reports. They presently have a $210.00 price objective on the stock. Chardan Capital’s price objective points to a potential upside of 65.93% from the stock’s previous close. PVLA has been the topic of […]

Orchestra BioMed (NASDAQ:OBIO – Get Free Report)‘s stock had its “buy” rating reissued by Chardan Capital in a research note issued on Thursday,Benzinga reports. They presently have a $20.00 price objective on the stock. Chardan Capital’s target price points to a potential upside of 356.62% from the company’s previous close. OBIO has been the topic […]

Ocugen (NASDAQ:OCGN – Get Free Report)‘s stock had its “buy” rating restated by Chardan Capital in a report released on Thursday,Benzinga reports. They presently have a $7.00 price target on the stock. Chardan Capital’s target price would indicate a potential upside of 334.78% from the stock’s previous close. Separately, Weiss Ratings reissued a “sell (e+)” […]

CervoMed (NASDAQ:CRVO – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at Chardan Capital in a report issued on Thursday,Benzinga reports. They presently have a $15.00 price target on the stock. Chardan Capital’s price target indicates a potential upside of 264.96% from the stock’s previous close. A number of other analysts […]

Ocugen (NASDAQ:OCGN – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Chardan Capital in a report issued on Thursday,Benzinga reports. They currently have a $7.00 price target on the stock. Chardan Capital’s price objective suggests a potential upside of 260.84% from the stock’s previous close. Separately, Weiss Ratings restated a “sell […]

ASML (NASDAQ:ASML – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at UBS Group in a report released on Tuesday,MarketScreener reports. ASML has been the topic of several other reports. Berenberg Bank reaffirmed a “buy” rating on shares of ASML in a report on Friday, January 23rd. Royal Bank Of Canada […]